Tumor Biomarker Test Market Report

Global and China Tumor Biomarker Test Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 07, 2022
  • PAGES：172
  • REPORT CODE：GMM1353620
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Tumor Biomarker Test industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Abbott Laboratories, Inc

    • Myriad Genetics Inc

    • Illumina Inc

    • Foundation Medicine Inc

    • AstraZeneca

    • Cancer Genetics Inc

    • Agilent Technologies

    • LabCorp Of America Holdings

    • Danaher Corporation

    • Biocept Inc

    • NanoString Technologies Inc

    • Becton Dickinson and Co

    • Luminex Corporation

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Prostate Specific Antigen Tests

    • CTC Tests

    • Alpha-Fetoprotein (AFP) Tests

    • CA Test

    • HER2 Tests

    • BRCA Test

    • Anaplastic Lymphoma Kinase (ALK) Tests

    • EGFR Mutation Tests

    • KRAS Test

    • Others

    Application:

    • Lung Cancer

    • Breast Cancer

    • Colorectal

    • Prostate Cancer

    • Blood Cancer

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Tumor Biomarker Test Industry Overview

      • 1.1.1 Tumor Biomarker Test Market Scope and Market Segments

      • 1.1.2 Tumor Biomarker Test Industry Characteristics

      • 1.1.3 Global and China Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Tumor Biomarker Test Production Value and Growth Rate (2017-2028)

    • 1.2 Global Tumor Biomarker Test Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Prostate Specific Antigen Tests

      • 1.2.2 CTC Tests

      • 1.2.3 Alpha-Fetoprotein (AFP) Tests

      • 1.2.4 CA Test

      • 1.2.5 HER2 Tests

      • 1.2.6 BRCA Test

      • 1.2.7 Anaplastic Lymphoma Kinase (ALK) Tests

      • 1.2.8 EGFR Mutation Tests

      • 1.2.9 KRAS Test

      • 1.2.10 Others

    • 1.3 Global Tumor Biomarker Test Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Lung Cancer

      • 1.3.2 Breast Cancer

      • 1.3.3 Colorectal

      • 1.3.4 Prostate Cancer

      • 1.3.5 Blood Cancer

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Tumor Biomarker Test Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Tumor Biomarker Test Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Tumor Biomarker Test Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Tumor Biomarker Test Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Tumor Biomarker Test Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Tumor Biomarker Test Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Tumor Biomarker Test Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Tumor Biomarker Test Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Tumor Biomarker Test Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Tumor Biomarker Test Industry Porter's Five Forces Model Analysis

      • 2.2.3 Tumor Biomarker Test Industry PEST Analysis

    • 2.3 Tumor Biomarker Test Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Tumor Biomarker Test Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Tumor Biomarker Test Industry

    Chapter 3 Global and China Tumor Biomarker Test Market, by Manufacturer

    • 3.1 Global and China Tumor Biomarker Test Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Tumor Biomarker Test Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Tumor Biomarker Test Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Tumor Biomarker Test Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Tumor Biomarker Test Market Top 3 Players

    Chapter 4 Global and China Tumor Biomarker Test Market, by Type (2017-2028)

    • 4.1 Tumor Biomarker Test Market Trend, by Type

    • 4.2 Global Tumor Biomarker Test Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Tumor Biomarker Test Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Tumor Biomarker Test Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Tumor Biomarker Test Price Trend, by Type (2017-2028)

    • 4.3 China Tumor Biomarker Test Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Tumor Biomarker Test Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Tumor Biomarker Test Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Tumor Biomarker Test Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Tumor Biomarker Test Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Tumor Biomarker Test Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Tumor Biomarker Test Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Tumor Biomarker Test Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Tumor Biomarker Test Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Tumor Biomarker Test Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Tumor Biomarker Test Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Tumor Biomarker Test Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Tumor Biomarker Test Market Analysis

    • 7.1 North America Tumor Biomarker Test Market, by Type

    • 7.2 North America Tumor Biomarker Test Market, by Application

    • 7.3 North America Tumor Biomarker Test Market Analysis and Forecast, by Country

      • 7.3.1 United States Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Tumor Biomarker Test Market Analysis

    • 8.1 Europe Tumor Biomarker Test Market, by Type

    • 8.2 Europe Tumor Biomarker Test Market, by Application

    • 8.3 Europe Tumor Biomarker Test Market Analysis and Forecast, by Country

      • 8.3.1 Germany Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Tumor Biomarker Test Market Analysis

    • 9.1 APAC Tumor Biomarker Test Market, by Type

    • 9.2 APAC Tumor Biomarker Test Market, by Application

    • 9.3 APAC Tumor Biomarker Test Market Analysis and Forecast, by Country

      • 9.3.1 China Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Tumor Biomarker Test Market Analysis

    • 10.1 Latin America, Middle East and Africa Tumor Biomarker Test Market, by Type

    • 10.2 Latin America, Middle East and Africa Tumor Biomarker Test Market, by Application

    • 10.3 Latin America, Middle East and Africa Tumor Biomarker Test Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Tumor Biomarker Test Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Tumor Biomarker Test Company Profiles

      • 11.1 Abbott Laboratories, Inc

        • 11.1.1 Abbott Laboratories, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Abbott Laboratories, Inc Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.1.3 Abbott Laboratories, Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Myriad Genetics Inc

        • 11.2.1 Myriad Genetics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Myriad Genetics Inc Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.2.3 Myriad Genetics Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Illumina Inc

        • 11.3.1 Illumina Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Illumina Inc Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.3.3 Illumina Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Foundation Medicine Inc

        • 11.4.1 Foundation Medicine Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Foundation Medicine Inc Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.4.3 Foundation Medicine Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 AstraZeneca

        • 11.5.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 AstraZeneca Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.5.3 AstraZeneca Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Cancer Genetics Inc

        • 11.6.1 Cancer Genetics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Cancer Genetics Inc Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.6.3 Cancer Genetics Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Agilent Technologies

        • 11.7.1 Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Agilent Technologies Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.7.3 Agilent Technologies Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 LabCorp Of America Holdings

        • 11.8.1 LabCorp Of America Holdings Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 LabCorp Of America Holdings Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.8.3 LabCorp Of America Holdings Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Danaher Corporation

        • 11.9.1 Danaher Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Danaher Corporation Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.9.3 Danaher Corporation Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Biocept Inc

        • 11.10.1 Biocept Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Biocept Inc Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.10.3 Biocept Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 NanoString Technologies Inc

        • 11.11.1 NanoString Technologies Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 NanoString Technologies Inc Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.11.3 NanoString Technologies Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Becton Dickinson and Co

        • 11.12.1 Becton Dickinson and Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Becton Dickinson and Co Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.12.3 Becton Dickinson and Co Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Luminex Corporation

        • 11.13.1 Luminex Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Luminex Corporation Tumor Biomarker Test Product Profiles, Application and Specification

        • 11.13.3 Luminex Corporation Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Tumor Biomarker Test Industry Investment Prospect and Risk Assessment

    • 12.1 Tumor Biomarker Test Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Tumor Biomarker Test Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure China Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Global Tumor Biomarker Test Production Value and Growth Rate (2017-2028)

    • Figure China Tumor Biomarker Test Production Value and Growth Rate (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Prostate Specific Antigen Tests (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of CTC Tests (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Alpha-Fetoprotein (AFP) Tests (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of CA Test (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of HER2 Tests (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of BRCA Test (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Anaplastic Lymphoma Kinase (ALK) Tests (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of EGFR Mutation Tests (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of KRAS Test (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Lung Cancer (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Breast Cancer (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Colorectal (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Prostate Cancer (2017-2028)

    • Figure Global Tumor Biomarker Test Market Size and Growth Rate of Blood Cancer (2017-2028)

    • Figure North America Tumor Biomarker Test Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Tumor Biomarker Test Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Tumor Biomarker Test Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Tumor Biomarker Test Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Tumor Biomarker Test Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Tumor Biomarker Test Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Tumor Biomarker Test Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Tumor Biomarker Test Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Tumor Biomarker Test Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Tumor Biomarker Test Market Share, by Manufacturer in 2021

    • Figure Global and China Tumor Biomarker Test Market Share, by Manufacturer in 2022

    • Table Global Tumor Biomarker Test Sales Volume, by Type (2017-2028)

    • Table Global Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Figure Global Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Table Global Tumor Biomarker Test Sales Value, by Type (2017-2028)

    • Table Global Tumor Biomarker Test Sales Value Share, by Type (2017-2028)

    • Figure Global Tumor Biomarker Test Price Trend, by Type (2017-2028)

    • Table China Tumor Biomarker Test Sales Volume, by Type (2017-2028)

    • Table China Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Figure China Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Table China Tumor Biomarker Test Sales Value, by Type (2017-2028)

    • Table China Tumor Biomarker Test Sales Value Share, by Type (2017-2028)

    • Figure China Tumor Biomarker Test Price Trend, by Type (2017-2028)

    • Table Global Tumor Biomarker Test Sales Volume, by Application (2017-2028)

    • Table Global Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure Global Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Table Global Tumor Biomarker Test Sales Value, by Application (2017-2028)

    • Table Global Tumor Biomarker Test Sales Value Share, by Application (2017-2028)

    • Figure Global Tumor Biomarker Test Sales Value Share, by Application (2017-2028)

    • Table China Tumor Biomarker Test Sales Volume, by Application (2017-2028)

    • Table China Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure China Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Table China Tumor Biomarker Test Sales Value, by Application (2017-2028)

    • Table China Tumor Biomarker Test Sales Value Share, by Application (2017-2028)

    • Figure China Tumor Biomarker Test Sales Value Share, by Application (2017-2028)

    • Figure China Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • Figure North America Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Tumor Biomarker Test Production, Import, Consumption and Export (2017-2022)

    • Table North America Tumor Biomarker Test Sales Volume, by Type (2017-2028)

    • Table North America Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Figure North America Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Table North America Tumor Biomarker Test Sales Volume, by Application (2017-2028)

    • Table North America Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure North America Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure United States Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure United States Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Canada Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Table Europe Tumor Biomarker Test Sales Volume, by Type (2017-2028)

    • Table Europe Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Figure Europe Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Table Europe Tumor Biomarker Test Sales Volume, by Application (2017-2028)

    • Table Europe Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure Europe Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure Germany Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure UK Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure UK Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure France Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure France Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Italy Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Spain Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Poland Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Russia Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Table APAC Tumor Biomarker Test Sales Volume, by Type (2017-2028)

    • Table APAC Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Figure APAC Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Table APAC Tumor Biomarker Test Sales Volume, by Application (2017-2028)

    • Table APAC Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure APAC Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure China Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure China Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Japan Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure India Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure India Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Tumor Biomarker Test Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Tumor Biomarker Test Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Tumor Biomarker Test Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Tumor Biomarker Test Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Tumor Biomarker Test Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Tumor Biomarker Test Sales Value and Growth Rate (2017-2028)

    • Table Abbott Laboratories, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories, Inc Product Profiles, Application and Specification

    • Table Abbott Laboratories, Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Myriad Genetics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Myriad Genetics Inc Product Profiles, Application and Specification

    • Table Myriad Genetics Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Illumina Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Illumina Inc Product Profiles, Application and Specification

    • Table Illumina Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Foundation Medicine Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Foundation Medicine Inc Product Profiles, Application and Specification

    • Table Foundation Medicine Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cancer Genetics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cancer Genetics Inc Product Profiles, Application and Specification

    • Table Cancer Genetics Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Agilent Technologies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Agilent Technologies Product Profiles, Application and Specification

    • Table Agilent Technologies Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table LabCorp Of America Holdings Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table LabCorp Of America Holdings Product Profiles, Application and Specification

    • Table LabCorp Of America Holdings Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Danaher Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Danaher Corporation Product Profiles, Application and Specification

    • Table Danaher Corporation Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Biocept Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Biocept Inc Product Profiles, Application and Specification

    • Table Biocept Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NanoString Technologies Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NanoString Technologies Inc Product Profiles, Application and Specification

    • Table NanoString Technologies Inc Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Becton Dickinson and Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Becton Dickinson and Co Product Profiles, Application and Specification

    • Table Becton Dickinson and Co Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Luminex Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Luminex Corporation Product Profiles, Application and Specification

    • Table Luminex Corporation Tumor Biomarker Test Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US